PubMed for id: 301

Year	Number of Results
1986	2
1987	1
1988	4
1989	1
1990	1
1991	2
1993	2
1995	1
1996	4
1998	1
1999	2
2000	4
2001	3
2002	3
2003	7
2004	15
2005	9
2006	13
2007	18
2008	17
2009	21
2010	28
2011	22
2012	31
2013	30
2014	34
2015	27
2016	23
2017	24
2018	24
2019	31
2020	28
2021	36
2022	29
2023	27
2024	4

1

An overview of the regulatory role of annexin A1 in the tumor microenvironment and its prospective clinical application (Review).

Gao K, Li X, Luo S, Zhao L. Gao K, et al. Int J Oncol. 2024 May;64(5):51. doi: 10.3892/ijo.2024.5639. Epub 2024 Mar 22. Int J Oncol. 2024. PMID: 38516766 Free PMC article. Review.

2

The expression of annexin-A1 in esophageal squamous cell carcinoma and its association with the biological behavior of the primary human esophageal squamous carcinoma cell line.

Li XJ, Li J, Zhang QQ, Su LP, Guo Y, Gong XL, Yao JJ, Wang L, Zhang ZQ. Li XJ, et al. J Physiol Pharmacol. 2023 Oct;74(5). doi: 10.26402/jpp.2023.5.07. Epub 2023 Dec 6. J Physiol Pharmacol. 2023. PMID: 38085519 Free article.

3

Annexin A1 may contribute to the morphological changes in podocytes by mediating endocytic vesicle fusion and transport via promotion of SNARE assembly in idiopathic membranous nephropathy.

Song L, Shen W, Wang L, Song J, Tu W, Ke B, Fang X. Song L, et al. Nephrology (Carlton). 2024 Feb;29(2):76-85. doi: 10.1111/nep.14247. Epub 2023 Nov 5. Nephrology (Carlton). 2024. PMID: 37927194

4

Targeting of Annexin A1 in Tumor-associated Macrophages as a therapeutic strategy for hepatocellular carcinoma.

Song Z, Wang X, Liu X, Luo Y, Qiu J, Yin A, Liu Y, Yi H, Xiao Z, Li A. Song Z, et al. Biochem Pharmacol. 2023 Jul;213:115612. doi: 10.1016/j.bcp.2023.115612. Epub 2023 May 19. Biochem Pharmacol. 2023. PMID: 37209858 Free article.

5

The Multifaceted Role of Annexin A1 in Viral Infections.

Resende F, Araújo S, Tavares LP, Teixeira MM, Costa VV. Resende F, et al. Cells. 2023 Apr 11;12(8):1131. doi: 10.3390/cells12081131. Cells. 2023. PMID: 37190040 Free PMC article. Review.

6

Downregulated annexin A1 expression correlates with poor prognosis, metastasis, and immunosuppressive microenvironment in Ewing's sarcoma.

Shi X, Wu Y, Tang L, Ni H, Xu Y. Shi X, et al. Aging (Albany NY). 2023 Mar 28;15(6):2321-2346. doi: 10.18632/aging.204615. Epub 2023 Mar 28. Aging (Albany NY). 2023. PMID: 36988561 Free PMC article.

7

Salivary annexin A1: A candidate biomarker for periodontitis.

Casarin RCV, Salmon CR, Stolf CS, Paz HES, Rangel TP, Domingues RR, Pauletti BA, Paes-Leme AF, Araújo C, Santamaria MP, Ruiz KS, Monteiro MF. Casarin RCV, et al. J Clin Periodontol. 2023 Jul;50(7):942-951. doi: 10.1111/jcpe.13803. Epub 2023 Mar 19. J Clin Periodontol. 2023. PMID: 36935103

8

ANXA1 mutation analysis in Italian patients with early onset PD.

Gagliardi M, Procopio R, Talarico M, Quattrone A, Arabia G, Morelli M, D'Amelio M, Malanga D, Bonapace G, Quattrone A, Annesi G. Gagliardi M, et al. Neurobiol Aging. 2023 May;125:123-124. doi: 10.1016/j.neurobiolaging.2023.01.014. Epub 2023 Jan 29. Neurobiol Aging. 2023. PMID: 36828691

9

Annexin A1 induces oxaliplatin resistance of gastric cancer through autophagy by targeting PI3K/AKT/mTOR.

Ren J, Hu Z, Niu G, Xia J, Wang X, Hong R, Gu J, Wang D, Ke C. Ren J, et al. FASEB J. 2023 Mar;37(3):e22790. doi: 10.1096/fj.202200400RR. FASEB J. 2023. PMID: 36786694

10

Knockdown of Annexin A1 induces apoptosis, causing G2/M arrest and facilitating phagocytosis activity in human leukemia cell lines.

Hasan M, Kumolosasi E, Jantan I, Jasamai M, Nazarudin N. Hasan M, et al. Acta Pharm. 2021 Aug 30;72(1):109-122. doi: 10.2478/acph-2022-0005. Print 2022 Mar 1. Acta Pharm. 2021. PMID: 36651527 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

473 results

Results by year